Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress

Endocrine-Related Cancer

Volumn 22, Issue 2, 2015, Pages 229-238

  Mihailidou, Chrysovalantou ^a   Chatzistamou, Ioulia ^b,c   Papavassiliou, Athanasios G ^a   Kiaris, Hippokratis ^a,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chaperone; Chemotherapy; Therapy; Unfolded protein response

Indexed keywords

BINDING PROTEIN; CASPASE 2; CASPASE 3; CASPASE 9; CCAAT ENHANCER BINDING PROTEIN; CHAPERONE; DOXORUBICIN; GLUCOSE REGULATED PROTEIN 94; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PROTEIN P21; PROTEIN P53; TUNICAMYCIN; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DDIT3 PROTEIN, MOUSE;

A549 CELL LINE; ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; CELL CYCLE REGULATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN GLYCOSYLATION; SENSITIVITY ANALYSIS; THERAPY EFFECT; UNFOLDED PROTEIN RESPONSE; ANIMAL; CELL CULTURE; DRUG POTENTIATION; GENETICS; KNOCKOUT MOUSE; LIVER NEOPLASMS; LUNG NEOPLASMS; METABOLISM; PHYSIOLOGY; SCID MOUSE; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOXORUBICIN; DRUG SYNERGISM; ENDOPLASMIC RETICULUM STRESS; FEMALE; FIBROBLASTS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MICE, SCID; TRANSCRIPTION FACTOR CHOP; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; TUNICAMYCIN; UNFOLDED PROTEIN RESPONSE;

EID: 84929306541     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-15-0019     Document Type: Article

References (26)

1. Ahmad M, Hahn IF & Chatterjee S 2014 GRP78 up-regulation leads to hypersensitization to cisplatin in A549 lung cancer cells. Anticancer Research 34 3493-3500.
2. Baptiste-Okoh N, Barsotti AM & Prives C 2008 Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle 7 1133-1138. (doi:10.4161/cc.7.9.5805)
3. Blagosklonny MV 2002 Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 1 391-393. (doi:10.4161/cc.1.6.262)
4. 21WAF1/CIP1 via C/EBPβ. Nature Medicine 3 1233-1241. (doi:10.1038/nm1197-1233)
5. waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells. Journal of Biological Chemistry 273 2008-2014. (doi:10.1074/jbc.273.4.2008)
6. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW & Vogelstein B 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75 817-825. (doi:10.1016/0092-8674(93)90500-P)
7. Dioufa N, Chatzistamou I, Farmaki E, Papavassiliou AG & Kiaris H 2012 p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress. Experimental Biology and Medicine 237 1173-1180. (doi:10.1258/ebm.2012.012140)
8. Farmaki E, Mkrtchian S, Papazian I, Papavassiliou AG & Kiaris H 2011 ERp29 regulates response to doxorubicin by a PERK-mediated mechanism. Biochimica et Biophysica Acta 1813 1165-1171. (doi:10.1016/j.bbamcr.2011.03.003)
9. Firczuk M, Gabrysiak M, Barankiewicz J, Domagala A, Nowis D, Kujawa M, Jankowska-Steifer E, Wachowska M, Glodkowska-Mrowka E, Korsak B et al. 2013 GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. Cell Death & Disease 4 e741. (doi:10.1038/cddis.2013.265)
10. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT &Weinberg RA 1994 Tumor spectrum analysis in p53-mutant mice. Current Biology 4 41-47. (doi:10.1016/S0960-9822(00)00002-6)
11. Leonova KI, Brodsky L, Lipchick B, Pal M, Novototskaya L, Chenchik AA, Sen GC, Komarova EA & Gudkov AV 2013 p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. PNAS 110 89-98. (doi:10.1073/pnas.1216922110)
12. Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S et al. 2014 The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicology Letters 224 333-340. (doi:10.1016/j.toxlet.2013-11.021)
13. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP & Ron D 2004 CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes and Development 18 3066-3077.
14. Mihailidou C, Papazian I, Papavassiliou AG & Kiaris H 2010 CHOP-dependent regulation of p21/waf1 during ER stress. Cellular Physiology and Biochemistry 25 761-766. (doi:10.1159/000315096)
15. Mihailidou C, Chatzistamou I, Papavassilou AG & Kiaris H 2015 Regulation of P21 during diabetes-associated stress of the endoplasmic reticulum. Endocrine-Related Cancer (In Press). (doi:10.1530/ERC-15-0018)
16. CDKN1A. Nature Communications 5 5067. (doi:10.1038/ncomms6067)
17. Oyadomari S & Mori M 2004 Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 11 381-389. (doi:10.1038/sj.cdd.4401373)
18. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, Hughes PD, Michalak EM, McKimm-Breschkin J, Motoyama N et al. 2007 ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129 1337-1349. (doi:10.1016/j.cell.2007.04.027)
19. Qu L, Huang S, Baltzis D, Rivas-Estilla A-M, Pluquet O, Hatzoglou M, Koumenis C, Taya Y, Yoshimura A & Koromilas AE 2004 Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β. Genes and Development 18 261-277. (doi:10.1101/gad.1165804)
20. Ron D & Walter P 2011 The unfolded protein response: from stress pathway to homeostatic regulation. Science 334 1081-1086. (doi:10.1126/science.1209038)
21. Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Letters 1 1-14. (doi:10.1016/S0304-3835(01)00847-3)
22. waf1/Cip1 in stromal fibroblasts of primary breast tumors. Human Molecular Genetics 17 3596-3600. (doi:10.1093/hmg/ddn252)
23. Ubeda M, Wang XZ, Zinszner H, Wu I, Habener JF & Ron D 1996 Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Molecular and Cellular Biology 16 1479-1489.
24. Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 6 425-429. (doi:10.1016/S1535-6108(03)00308-8)
25. Zhang F, Hamanaka RB, Bobrovnikova-Marjon E, Gordan JD, Dai M-S, Lu H, Simon MC & Diehl JA 2006 Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. Journal of Biological Chemistry 281 30036-30045. (doi:10.1074/jbc.M604674200)
26. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL & Ron D 1998 CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes and Development 12 982-995. (doi:10.1101/gad.12.7.982)